IntelGenx Technologies Corp. (OTCMKTS:IGXT – Get Free Report) shares traded up 7.2% on Monday . The company traded as high as $0.16 and last traded at $0.15. 153,486 shares changed hands during trading, an increase of 31% from the average session volume of 117,349 shares. The stock had previously closed at $0.14.
IntelGenx Technologies Stock Up 7.2 %
The company has a market cap of $26.22 million, a price-to-earnings ratio of -2.15 and a beta of 2.39. The stock has a fifty day moving average price of $0.13 and a two-hundred day moving average price of $0.16.
IntelGenx Technologies (OTCMKTS:IGXT – Get Free Report) last posted its earnings results on Thursday, November 9th. The company reported ($0.01) earnings per share for the quarter. The firm had revenue of $0.32 million during the quarter.
IntelGenx Technologies Company Profile
IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 and INT0055/2021 are for adult use; INT0007/2006, an oral film product for treatment of erectile dysfunction; INT0043/2015, an oral film containing montelukast for treatment of Alzheimer; INT0027/2011 to treat opioid addition; INT0010/2006 for treatment of neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, an oral film product for schizophrenia or bipolar 1 disorder; and INT0048/2020 for animal health.
- Five stocks we like better than IntelGenx Technologies
- What Are Dividend Champions? How to Invest in the Champions
- The most upgraded stocks in November have two things in common
- What is the Dogs of the Dow Strategy? Overview and Examples
- Monday.com rocked earnings like it’s the weekend
- Conference Calls and Individual Investors
- Plan to own one retailer? Make it this one
Receive News & Ratings for IntelGenx Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntelGenx Technologies and related companies with MarketBeat.com's FREE daily email newsletter.